Slingshot members are tracking this event:
AstraZeneca's (AZN) Phase 3 KESTREL and EAGLE Clinical Trials for Durvalumab in Head and Neck Cancer Suspended by FDA
Slingshot Insights Explained
Oct 27, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3, Kestrel, Eagle, Durvalumab, Head And Neck Cancer, Fda, Trial Suspension, Bleeding